Reactive Oxygen Species in Diabetes

Reactive oxygen species (ROS) are highly reactive molecules that serve dual functions in diabetes. Although ROS are necessary for normal cellular signaling, excessive production—often due to high blood sugar—can trigger oxidative stress, harming cells and tissues. In diabetes, elevated ROS levels contribute to insulin resistance, damage blood vessels, and impair pancreatic beta cells, exacerbating disease progression. Oxidative stress from excess ROS also fuels inflammation and accelerates long-term complications like retinopathy and neuropathy. Treatments focusing on antioxidants or reducing ROS production can improve insulin sensitivity and mitigate these harmful effects. Balancing ROS production and removal is essential for developing effective diabetes therapies and reducing complications.

Committee Members
Speaker at Diabetes  2026 - Mahir Khalil Ibrahim Jallo

Mahir Khalil Ibrahim Jallo

Gulf Medical University, Canada
Speaker at Diabetes  2026 - F Buck Willis

F Buck Willis

Christian College of Medicine, Belize
Speaker at Diabetes  2026 - Anil Harrison

Anil Harrison

Midwestern University, United States
Speaker at Diabetes  2026 - Wan Rosli Wan Ishak

Wan Rosli Wan Ishak

Universiti Sains Malaysia, Malaysia
Diabetes 2026 Speakers
Speaker at Diabetes  2026 - Mahir Khalil Ibrahim Jallo

Mahir Khalil Ibrahim Jallo

Gulf Medical University, Canada
Speaker at Diabetes  2026 - F Buck Willis

F Buck Willis

Christian College of Medicine, Belize
Speaker at Diabetes  2026 - Anil Harrison

Anil Harrison

Midwestern University, United States
Speaker at Diabetes  2026 - David Navazio

David Navazio

Gentell, United States
Speaker at Diabetes  2026 - Sujith Rajan

Sujith Rajan

NYU Long Island School of Medicine, United States
Speaker at Diabetes  2026 - David Petch

David Petch

utR Biotech, Canada
Tags

Submit your abstract Today

YouTube
WhatsAppWhatsApp